Your browser is no longer supported. Please, upgrade your browser.
TEVA Teva Pharmaceutical Industries Limited monthly Stock Chart
TEVA [NYSE]
Teva Pharmaceutical Industries Limited
Index- P/E- EPS (ttm)-3.42 Insider Own2.70% Shs Outstand1.17B Perf Week-11.02%
Market Cap9.65B Forward P/E3.20 EPS next Y2.57 Insider Trans0.51% Shs Float1.05B Perf Month-27.97%
Income-3523.00M PEG- EPS next Q0.57 Inst Own62.20% Short Float3.45% Perf Quarter-50.09%
Sales18.08B P/S0.53 EPS this Y87.00% Inst Trans-1.98% Short Ratio2.32 Perf Half Y-56.61%
Book/sh13.52 P/B0.61 EPS next Y8.52% ROA-5.60% Target Price16.48 Perf Year-66.13%
Cash/sh1.68 P/C4.89 EPS next 5Y-2.45% ROE-24.70% 52W Range8.19 - 25.96 Perf YTD-46.56%
Dividend- P/FCF21.49 EPS past 5Y-28.50% ROI-3.20% 52W High-67.99% Beta1.61
Dividend %- Quick Ratio0.60 Sales past 5Y-1.50% Gross Margin43.10% 52W Low1.47% ATR0.60
Employees42535 Current Ratio1.00 Sales Q/Q-15.20% Oper. Margin-16.70% RSI (14)24.34 Volatility5.55% 5.96%
OptionableYes Debt/Eq1.94 EPS Q/Q-114.70% Profit Margin-19.70% Rel Volume1.15 Prev Close8.24
ShortableYes LT Debt/Eq1.75 EarningsMay 02 BMO Payout- Avg Volume15.58M Price8.31
Recom2.80 SMA20-15.07% SMA50-33.89% SMA200-53.40% Volume11,217,501 Change0.85%
Jun-11-19Initiated Barclays Underweight $8
Jun-03-19Upgrade Oppenheimer Perform → Outperform $12
May-30-19Downgrade BofA/Merrill Buy → Underperform
May-28-19Downgrade UBS Buy → Neutral
Mar-20-19Initiated SunTrust Hold
Mar-07-19Resumed UBS Buy $22
Mar-06-19Downgrade Morgan Stanley Overweight → Equal-Weight $17
Feb-20-19Downgrade Mizuho Buy → Neutral $25 → $18
Feb-14-19Upgrade Raymond James Mkt Perform → Outperform $22
Jan-23-19Upgrade UBS Neutral → Buy
Jan-23-19Upgrade Piper Jaffray Underweight → Neutral
Jan-03-19Upgrade BofA/Merrill Underperform → Buy
Nov-05-18Upgrade Morgan Stanley Equal-Weight → Overweight
Oct-01-18Upgrade Leerink Partners Underperform → Mkt Perform
Sep-21-18Resumed Oppenheimer Perform
Sep-17-18Upgrade BTIG Research Sell → Neutral
Sep-07-18Downgrade Credit Suisse Outperform → Neutral
Jun-27-18Reiterated Citigroup Buy $25 → $27
Mar-20-18Resumed Jefferies Hold $19
Feb-12-18Upgrade Credit Suisse Neutral → Outperform
Jun-17-19 10:21AM  Teva Stock Keeps Sinking Because Opioid Lawsuits Arent Going Away Barrons.com
Jun-13-19 05:45PM  Teva Pharmaceutical Industries Ltd. (TEVA) Stock Sinks As Market Gains: What You Should Know Zacks
04:12PM  The Opioid Epidemic Will Be A Yearslong Overhang For These Pharma Stocks Investor's Business Daily
11:59AM  The Opioid Epidemic Will Be A Yearslong Overhang For These Pharma Stocks Investor's Business Daily
08:36AM  3 Big Stock Charts for Thursday: H & R Block, Twitter and Philip Morris InvestorPlace
Jun-12-19 04:17PM  Pharma Giant Nears Two-Decade Low As Opioid Settlement Remains In Limbo Investor's Business Daily
11:10AM  Teva Retests Lows After Judge Declines Settlement Offer Investopedia
10:23AM  Short Sellers Are Making Bigger Bets Against Teva and Allergan Stock Barrons.com
06:29AM  Barclays Has New Plays for Healthcare Fans SmarterAnalyst
Jun-10-19 10:27AM  Hedge Funds Are Dumping Teva Pharmaceutical Industries Limited (TEVA) Insider Monkey
Jun-09-19 04:28PM  Notable Insider Buys This Past Week: American Airlines, MGM and More Benzinga
Jun-07-19 07:48PM  Why Investors Should Keep an Eye on the Oklahoma Opioid Trial Against Johnson & Johnson Motley Fool
05:45PM  Teva Pharmaceutical Industries Ltd. (TEVA) Stock Sinks As Market Gains: What You Should Know Zacks
05:00PM  Celgene's Filing for Ozanimod Accepted for Review in US/EU Zacks
09:36AM  Teva and J&J Stocks Were Hit by Opioid Worries. What Could Come Next. Barrons.com
Jun-06-19 09:22AM  Lilly's Emgality Gets FDA Approval for Cluster Headache Zacks
07:00AM  Teva Stock Sees Another Big Buy From Chairman Sol Barer Barrons.com
Jun-04-19 05:06PM  FDA approves Lilly's migraine drug as first ever cluster headache treatment Reuters +7.08%
04:21PM  How Much Could Generic Pharmas Have To Fork Over In Antitrust Lawsuit? Investor's Business Daily
Jun-03-19 01:45PM  Teva Stock Has Crumbled, and Chairman Sol Barer Is Buying Up Shares Barrons.com
11:40AM  Teva Pharmaceutical Gets Reprieve After Analyst Upgrade Investopedia
11:08AM  Teva Pharmaceutical Stock Jumps on a Rare Bullish Take Barrons.com
10:30AM  Teva Shares Rebound on Oppenheimer Upgrade TheStreet.com
May-31-19 09:07AM  Biogen Reports Interim Phase III Data on Diroximel Fumarate Zacks
May-30-19 12:52PM  If You Had Bought Teva Pharmaceutical Industries (NYSE:TEVA) Stock Three Years Ago, You'd Be Sitting On A 82% Loss, Today Simply Wall St. -8.87%
10:17AM  Teva stock downgraded by Bank of America Merrill Lynch MarketWatch
10:06AM  Teva Stock Is Falling Because an Analyst Says the Company Needs Numerous Litigation Wins Barrons.com
08:39AM  Here are the biggest analyst calls of the day: Tesla, Apple, Citi, Verizon & more CNBC
07:33AM  The Daily Biotech Pulse: Unity Biotech Licenses Anti-Aging Protein, Strong Results For Mereo's Brittle Bone Disease Drug Benzinga
May-29-19 03:24PM  Teva Pharmaceutical Shares Flag Red Investopedia
02:23PM  Teva's Legal Overhang Triggers UBS Downgrade, Near-Halving Of Price Target Benzinga
02:12PM  J&J Slide Deepens as Legal Woes Weigh on Shares Again Bloomberg
10:32AM  Teva Pharmaceutical Industries Ltd -- Moody's: Teva's opioid settlement with the State of Oklahoma is credit negative Moody's
10:31AM  Lilly In-Licenses Private Biotech's Non-Opoid Pain Candidate Zacks
09:47AM  Wednesdays Vital Data: Teva Pharmaceuticals, Advanced Micro Devices and General Electric InvestorPlace
09:42AM  Teva Settles With Oklahoma, Shares Fall Following Downgrade Zacks
09:34AM  Company News For May 29, 2019 Zacks
09:33AM  Market Morning: Huawei Sues, Rare Earth Pawns, 737s Back by August? Market Exclusive
08:27AM  Should You Sell J&J Stock As Opioid Charges Heat Up? InvestorPlace
07:47AM  Teva stock downgraded to neutral by UBS on heels of $85 million opioid settlement MarketWatch
02:00AM  Teva to present new fremanezumab FOCUS Clinical Study Data for the first time at the 13th European Headache Federation Congress Business Wire
May-28-19 05:15PM  Teva Plummets on Downgrade Following $85M Opioid Settlement TheStreet.com -12.42%
04:33PM  Why Teva Pharmaceutical Industries, Seadrill, and Nutanix Slumped Today Motley Fool
04:20PM  Pharma Giant Crashes To 19-Year Low On Generic Drugs Lawsuit Investor's Business Daily
04:18PM  5 Top Stock Trades for Wednesday: GILD, NVDA, AMD InvestorPlace
01:11PM  Here's Why Teva Pharmaceutical Is Sinking Today Motley Fool
12:45PM  Teva Announces Launch of a Generic Version of Ranexa® (ranolazine) Extended-Release Tablets in the United States Business Wire
12:09PM  Teva reaches settlement with Oklahoma to resolve opioid claims American City Business Journals
11:21AM  Oklahoma prosecutors blast J&J in first day of landmark opioid trial. State says drugmaker ran 'deceitful, multibillion-dollar brainwashing campaign' CNBC
10:08AM  Teva Pharmaceuticals Could Face Billions in Damages From Opioid Lawsuits, Analyst Says Barrons.com
06:25AM  Fiat Chrysler, Renault, Alibaba, Teva and Huawei - 5 Things You Must Know TheStreet.com
May-27-19 02:37PM  Teva Settles With Oklahoma Over Opioid Allegations TheStreet.com
May-26-19 09:01PM  PRESS DIGEST- Financial Times - May 27 Reuters
04:32PM  Teva settles opioid lawsuit with Oklahoma for $85 million MarketWatch
03:35PM  Teva Pharm to pay Oklahoma $85 million to settle opioid claims Reuters
12:55PM  Teva settles with Oklahoma for $85 million in opioid case Associated Press
12:41PM  Teva Pharm to pay Oklahoma $85 million to settle opioid claims Reuters
12:29PM  Teva Pharm to pay Oklahoma $85 mln to settle opioid claims Reuters
12:08PM  Oklahoma reaches $85 million settlement with Teva Pharmaceuticals ahead of trial Reuters
11:22AM  Oklahoma reaches $85 mln settlement with Teva Pharmaceuticals ahead of trial Reuters
10:30AM  Company Statement: Teva Reaches Agreement with State of Oklahoma to Resolve States Claims Against the Company Business Wire
02:58AM  Teva to pay $85m to Oklahoma over opioid case Financial Times
May-24-19 06:07PM  6 Warren Buffett Holdings Near 52-Week Lows GuruFocus.com
05:02PM  An Antitrust Lawsuit Could Cost Generic Pharmas Billions Of Dollars Investor's Business Daily
10:20AM  Drug Makers' Opioid Liability Tied to Untested Legal Theory Bloomberg
12:23AM  Deckers Outdoor Corp (DECK) Q4 2019 Earnings Call Transcript Motley Fool
May-23-19 12:07PM  This May Hurt a Little (Or a Lot) as Opioids Haunt Pharma Bonds Bloomberg
May-22-19 08:49AM  Better Turnaround Play: Bausch Health Companies or Teva Pharmaceutical Industries Motley Fool
May-20-19 04:05PM  TEVA INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 Investing In Teva Pharmaceutical Industries Limited To Contact The Firm ACCESSWIRE
12:04PM  Credit Suisse Absolutely Is Right to Double Down on Pfizer Stock InvestorPlace
May-18-19 11:44AM  Warren Buffett Stocks Fall: Teva Pharmaceutical Up 1.8%; StoneCo Off 3.7% TheStreet.com
May-17-19 05:19PM  Roche Gets FDA Nod for Venclexta Plus Gazyva to Treat CLL Zacks
May-16-19 04:07PM  6 Positions the Vanguard Health Care Fund Continues to Increase GuruFocus.com
08:00AM  Generic Drugs Are Stabilizing Can They Survive An Antitrust Scandal? Investor's Business Daily
May-15-19 11:47AM  Teva Hits Fibonacci Support on Concerns Over Lawsuit Investopedia -5.45%
10:30AM  Mylan's stock falls toward 7 1/2-year low; credit rating now in danger of downgrade to 'junk' at Fitch MarketWatch
09:24AM  The Zacks Analyst Blog Highlights: Teva, Mylan, Novartis and Pfizer Zacks
May-14-19 12:50PM  Options Traders Making Big Long-Term Bets On Teva Benzinga
10:18AM  Company News For May 14, 2019 Zacks
09:56AM  The Zacks Analyst Blog Highlights: Teva, Amazon, Berkshire and JPMorgan Zacks
09:18AM  Generic Drugmakers Face Antitrust Suit Alleging Price Fixing Zacks
May-13-19 05:49PM  TEVA INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 Investing In Teva Pharmaceutical Industries Limited To Contact The Firm PR Newswire -14.83%
05:46PM  States Expand Suit Against Teva & Others, Shares Plunge Zacks
05:38PM  Generic Drug Makers: The Largest 'Cartel' In U.S. History? Investor's Business Daily
05:06PM  What Happened in the Stock Market Today Motley Fool
04:35PM  Teva and Apple fall while Newmont Goldcorp and NextEra rise Associated Press
04:08PM  Dow Ends Sharply Lower; Trade War Escalation Slams Stocks TheStreet.com
03:42PM  5 Top Stock Trades for Tuesday: Amazon, Teva, S&P 500 InvestorPlace
02:47PM  Teva Stock Is Sinking as a Lawsuit Alleges a Drug-Pricing Conspiracy Barrons.com
02:33PM  How Low Can Teva Pharmaceutical Stock Go? Don't Fight the Tape TheStreet.com
02:02PM  Why Teva Pharmaceutical Is Getting Hammered Today Motley Fool
01:23PM  Teva Falls as Drugmakers Alleged to Have Artificially Inflated Prices TheStreet.com
01:06PM  Stocks making the biggest moves midday: Teva Pharmaceutical, Boeing, Uber & more CNBC
12:42PM  Forty-four states accuse Teva Pharmaceutical of inflating drug prices CNBC Videos
12:35PM  Endo Pharmaceutical Falls After Downgrade to Underweight at JPMorgan TheStreet.com
12:26PM  Teva Pharmaceutical drops 16% after 44 states accuse drugmaker of conspiring to hike generic drug prices CNBC
11:56AM  The Late Morning Rundown: May 13, 2019 CNBC Videos
10:43AM  Teva Pharmaceutical Put Volume Pops on Lawsuit Woes Schaeffer's Investment Research
08:40AM  Teva Plummets Amid Massive Price Fixing Accusations; Other Generic Drugmakers Also Fall Benzinga
07:57AM  Stocks making the biggest moves premarket: Disney, Teva Pharmaceuticals, Uber, Pinterest & more CNBC
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines and a portfolio of specialty medicines worldwide. It operates through two segments, Generic Medicines and Specialty Medicines. The Generic Medicines segment offers sterile products, hormones, narcotics, high-potency drugs, and cytotoxic substances in various dosage forms, including tablets, capsules, injectables, inhalants, liquids, ointments, and creams. This segment also develops, manufactures, and sells active pharmaceutical ingredients. The Specialty Medicines segment provides specialty medicines for use in central nervous system and respiratory indications. Its products in the central nervous system area comprise Copaxone for the treatment of relapsing forms of MS; and AUSTEDO for the treatment of tardive dyskinesia and chorea associated with Huntington disease. This segment's products in the respiratory market include ProAir, ProAir Respiclick, QVAR, Duoresp Spiromax, Qnasl, Braltus, Cinqair/Cinqaero, and Aerivio Spiromax for the treatment of asthma and chronic obstructive pulmonary disease, as well as Bendeka, Treanda, Granix, Trisenox, Lonquex, and Tevagrastim/Ratiograstim products in the oncology market. The company has collaboration arrangements with Otsuka Pharmaceutical Co. Ltd. and Regeneron Pharmaceuticals, Inc. Teva Pharmaceutical Industries Limited was founded in 1901 and is headquartered in Petach Tikva, Israel.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
BARER SOL JDirectorJun 04Buy9.60104,5001,003,409220,442Jun 05 07:02 AM
BARER SOL JDirectorJun 03Buy8.98111,000997,013115,942Jun 03 11:21 AM
de Notaristefani CarloExecutive VP Global OperationsMay 20Sale11.4216,070183,51933,589May 21 06:38 AM
de Notaristefani CarloExecutive VP Global OperationsMay 16Sale11.766297,39718,784May 20 07:18 AM
O'Grady Brendan P.EVP, North America CommercialMar 18Sale16.631,17919,6011,388Mar 19 08:29 AM
Nazzi GianfrancoEVP, Growth Markets CommercialMar 18Sale16.643205,3269,002Mar 19 08:17 AM
Daniell RichardExec. VP, European CommercialMar 18Sale16.641,29721,5880Mar 19 08:14 AM
Stark David MatthewExec. VP Chief Legal OfficerMar 18Sale16.432,35838,7422,974Mar 19 08:11 AM
McClellan Michael JamesEVP, Chief Financial OfficerMar 18Sale16.632303,82412,760Mar 19 08:08 AM
Griffin Deborah AChief Accounting OfficerMar 18Sale16.6394315,6770Mar 19 08:06 AM
Fridriksdottir HafrunExecutive VP, Global R&DMar 18Sale16.633565,91916,750Mar 19 08:04 AM
Dethlefs SvenEVP Global Marketing&PortfolioMar 18Sale16.6363210,5079,149Mar 19 08:02 AM
Stark David MatthewExec. VP Chief Legal OfficerMar 12Sale15.822,44438,6642,974Mar 14 07:44 AM
O'Grady Brendan P.EVP, North America CommercialMar 12Sale15.6773811,5681,388Mar 14 07:41 AM
Nazzi GianfrancoEVP, Growth Markets CommercialMar 12Sale15.693255,0998,450Mar 14 07:36 AM
Griffin Deborah AChief Accounting OfficerMar 12Sale15.6795314,9380Mar 14 07:33 AM
Dethlefs SvenEVP Global Marketing&PortfolioMar 12Sale15.6764710,1428,602Mar 14 07:31 AM
Daniell RichardExec. VP, European CommercialMar 12Sale15.6971511,2180Mar 14 07:28 AM
O'Grady Brendan P.EVP, North America CommercialMar 04Sale16.881,16619,6861,388Mar 05 07:36 AM
McClellan Michael JamesEVP, Chief Financial OfficerMar 04Sale16.883636,12912,330Mar 05 07:28 AM
Griffin Deborah AChief Accounting OfficerMar 04Sale16.884,10769,3400Mar 05 07:23 AM
Fridriksdottir HafrunExecutive VP, Global R&DMar 04Sale16.884096,90516,094Mar 05 07:16 AM
Dethlefs SvenEVP Global Marketing&PortfolioMar 04Sale16.8860610,2318,058Mar 05 07:10 AM
Daniell RichardExec. VP, European CommercialMar 04Sale16.882,09835,4230Mar 05 07:05 AM
Nazzi GianfrancoEVP, Growth Markets CommercialMar 04Sale16.885128,6457,892Mar 05 08:20 AM
Stark David MatthewExec. VP Chief Legal OfficerFeb 14Sale17.743,92669,6472,974Feb 19 07:26 AM
de Notaristefani CarloExecutive VP Global OperationsFeb 14Sale17.673,19256,39918,209Feb 19 07:05 AM
Fridriksdottir HafrunExecutive VP, Global R&DFeb 14Sale17.671,84132,52915,338Feb 19 07:11 AM
de Notaristefani CarloExecutive VP Global OperationsFeb 13Sale17.885,04190,10812,121Feb 14 07:43 AM
Fridriksdottir HafrunExecutive VP, Global R&DJan 02Sale15.701,64325,79911,826Jan 03 07:24 AM
Fridriksdottir HafrunExecutive VP, Global R&DNov 30Sale21.7693320,3048,829Dec 04 08:09 AM
McClellan Michael JamesEVP, Chief Financial OfficerNov 05Sale22.733467,86511,644Nov 07 06:38 AM
O'Grady Brendan P.EVP, North America CommercialSep 18Sale23.711,24129,4201,388Sep 20 04:10 PM
Nazzi GianfrancoEVP, Growth Markets CommercialSep 18Sale23.691,37932,6707,005Sep 20 04:09 PM
Griffin Deborah AChief Accounting OfficerSep 18Sale23.712,37656,3280Sep 20 04:08 PM
Dethlefs SvenEVP Global Marketing&PortfolioSep 18Sale23.7162514,8177,265Sep 20 04:06 PM
Daniell RichardExec. VP, European CommercialSep 18Sale23.692,48858,9430Sep 20 04:04 PM
Daniell RichardExec. VP, European CommercialSep 10Sale21.2569614,7900Sep 11 04:17 PM
Codner Iris BeckEVP Global Brand&CommunicationAug 09Sale22.704,16594,5418,290Aug 13 08:34 AM
Dethlefs SvenEVP Global Marketing&PortfolioAug 03Buy21.922,00043,8406,445Aug 07 09:45 AM